In this episode of Glom Goals, we spoke to Dr. Salil Parikh from the Methodist Le Bonheur Healthcare group in Tennessee to understand how his facility has achieved such great biopsy adequacy rates. We'll dive into their approach to performing renal biopsies—an approach that consistently delivers excellent and adequate samples. While it might not be the only way to do it, it’s a blueprint that we know works and it can help refine how we all approach kidney biopsies.Join us as we break down what makes this approach successful, discuss tips for optimizing yield and safety, and reflect on how you can adapt it in your own practice. What’s your biopsy blueprint—and what outcomes have you seen?Here is a link to a paper that was frequently referenced during this episode: https://pubmed.ncbi.nlm.nih.gov/20574102/

Renal pathologists Dr. Shree Sharma and Dr. Tiff Caza sit down with nephrologists Dr. Juan Carlos Velez, Dr. Bill Whittier, and Dr. Vandana Dua Niyyar to discuss the rising renal biopsy inadequacy crisis. They investigate what the root cause of this crisis may be, as well as discussing what possible solutions could look like.

This podcast was produced by Arkana Laboratories. For more context on this crisis, check out our Arkana Advances podcast.